Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation
MrMAPP
Feasibility and Functional Outcomes of a Novel Mixed Reality Based System to Manage Phantom Pain for Patients With Lower Limb Amputation.
1 other identifier
interventional
11
1 country
1
Brief Summary
The primary goals of this pilot research project are a) to design and develop the a mixed reality based system for managing phantom pain and b) to evaluate the feasibility and preliminary functional outcomes of this system in a sample of patients with lower limb amputation. Findings from this pilot study will serve as preliminary data to inform regarding a fully powered clinical trial to determine the effectiveness and practical implementation of these findings in real-world settings. Aim1: Design and develop a feasible mixed reality based system to manage phantom pain in patients with lower limb amputation qualifying for on-going mirror therapy. Hypothesis 1: The investigators hypothesize that the mixed reality based system to manage phantom pain will be feasible and well-received by a sample of patients with lower limb amputation needing mirror therapy. Aim2: Evaluate functional outcomes in a sample of lower limb amputees (n=10), using this mixed reality based system to manage phantom pain. Hypothesis 2: Using this system, the investigators hypothesize that patients who participate in the mixed reality based system will show improvements in functional mobility based on performance evaluations and patient reported outcome measures (PROs). The investigators also hypothesize that this mixed reality based system will help to alleviate the phantom pain based on McGill Pain questionnaire and visual analog scale (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 21, 2018
CompletedFirst Submitted
Initial submission to the registry
August 24, 2020
CompletedFirst Posted
Study publicly available on registry
August 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedResults Posted
Study results publicly available
July 3, 2024
CompletedJuly 3, 2024
March 1, 2024
4.2 years
August 24, 2020
April 9, 2023
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Numerical Rating Scale
Pain intensity; 0-10; higher is worse
baseline, 1-month
Change in McGill Pain Questionnaire
Pain intensity and interference; multiple scales; higher is worse. Range 0-78
baseline, 1-month
Secondary Outcomes (1)
Change in Patient Specific Functional Questionnaire
baseline, 1-month
Study Arms (1)
Intervention
EXPERIMENTALMixed Reality System for virtual mirror therapy
Interventions
Mixed reality device to provide virtual mirror therapy to patients with phantom pain
Eligibility Criteria
You may qualify if:
- Men and women, over the age of 18 with lower limb amputations (greater than 3 months post surgery) with phantom limb pain
You may not qualify if:
- Patients with lower limb amputations with open wounds or active infection in residual or contralateral limbs.
- Patients with history of seizures.
- Patients with visual (self-reported) or cognitive impairment (assessed by the mini-mental state examination) that interferes with ability to interact with, participate in, and adhere to a computerized rehabilitation system.
- Any patient with a cardiac event in the last 6 months.
- Any patient with an active medical issue to minimize risk of exacerbating their condition.
- Lives more than 60 miles away from the Dallas VA Medical Center
- Any patient with the motion sickness induced by head mounted displays (HMDs) or immersive environment.
- Any patient experiencing the motion sickness induced by HMDs during the therapy session can also opt out of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dallas VA Medical Centerlead
- The University of Texas at Dallascollaborator
Study Sites (1)
VA North Texas Health Care System
Dallas, Texas, 75216, United States
Related Publications (2)
Annapureddy D, Annaswamy TM, Raval G, Chung YY, Prabhakaran B. A novel mixed reality system to manage phantom pain in-home: results of a pilot clinical trial. Front Pain Res (Lausanne). 2023 Jun 2;4:1183954. doi: 10.3389/fpain.2023.1183954. eCollection 2023.
PMID: 37332478DERIVEDAnnaswamy TM, Bahirat K, Raval G, Chung YY, Pham T, Prabhakaran B. Clinical feasibility and preliminary outcomes of a novel mixed reality system to manage phantom pain: a pilot study. Pilot Feasibility Stud. 2022 Oct 22;8(1):232. doi: 10.1186/s40814-022-01187-w.
PMID: 36273191DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. James Le Page
- Organization
- VA North Texas Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Gargi Raval, MD
North Texas Veterans Healthcare System
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Physician and Professor
Study Record Dates
First Submitted
August 24, 2020
First Posted
August 27, 2020
Study Start
May 21, 2018
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
July 3, 2024
Results First Posted
July 3, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Data may be shared upon approval from concerned authorities if needed